Tranexamic acid / 传明酸
Ingredient overview
A 2019 randomized study compared specified topical preparations in melasma patients over 12 weeks. It provides research context for a tone-care discussion, not permission to market every formula as a cosmetic.
Read the sources
- Topical tranexamic acid trial · Janney et al., 2019Primary clinical study; patients with melasma, not AURVONX products
- Cosmetic, drug, or both? · US FDAUS classification guidance
What the evidence can and cannot tell you
Ingredient studies and supplier materials describe particular substances, concentrations, vehicles, use conditions or test methods. They do not establish the performance, safety or claim support of a new AURVONX project formula.
For a project, confirm the exact ingredient identity and grade, level, supplier specification, formula compatibility, stability and preservation, intended use, destination-market rules and evidence for the finished product.
From ingredients to your product range
Consider the ingredient within the complete product: its format, texture, application area and place in the routine. Discuss your preferred ingredient direction with our team.